NASDAQ-100

278.50 0.32%

1M0.00% 1Y -0.00%  

Analysts Review about Biogen Inc. Common Stock

Market Consensus (16 Analysts)

Strong Buy

Price Target High $349.01

Spread: 25.72%

Price Target Average $335.59

Spread: 20.88%

Price Target Low $264.20

Spread: -4.84%

Technical Analyses Trend

Periods

Trend

Resistance

Support

Short Term

Bullish

219.02 (-21.36%)

213.97 (-23.17%)

Mid Term

Bullish

250.19 (-10.17%)

213.97 (-23.17%)

Long Term

Bullish

299.76 (7.63%)

213.97 (-23.17%)

  • 1W
  • 1M
  • 1Y

Biogen Inc. Common Stock Articles

Prediction: These 6 AI Stocks Will Be Worth a Combined $20 Trillion by 2030

The top six AI stocks are currently worth a combined $9.5 trillion. They could reach $20 trillion or more by 2030 via different paths, with AI serving as a key tailwind.

Sentiment: Positive 2023-05-30


Sirius Real Estate completes early refinancing of debt

Sirius Real Estate said it completed the early refinancing of its €58.3mln debt facility with Deutsche Pfandbriefbank seven months before the due date. A statement from the owner and operator of business and industrial parks said the refinancing comprises a seven-year €58.3mln facility with a fixed interest rate of 4.25%.

Sentiment: Positive 2023-05-30


Loan Growth Supports M&T Bank (MTB) Despite Rising Costs

M&T Bank's (MTB) top line gets support from increasing loan and deposit balances. Continued rising expenses keep the bottom line under pressure, while worsening credit quality is worrisome.

Sentiment: Negative 2023-05-30


S&P Stocks Review about Biogen Inc. Common Stock

SPS Rank 559th

SPS Rate 4.1

SPS Consensus (08 Analysts) Hold

Target Price 195.93 USD NA

Potentials Excellent

Growth (Revenue) Extremely Poor

Finances Fair

Profitability Very Good

Earnings Quality Good

P/E Ratio Poor

Valuation Overvalued

Fair Value 113.20USD -59.35%

Source

Sentiment

Biogen Inc. Common Stock Overview 30 Nov 2020

Open 278.93

High 280.86

Low 276.40

1 Day Change (Last) 0.88

1 Day Change Percent (Last) 0.32%

Close 278.50

Previous Close 277.62

Volume 373,033

52 Week High 319.76

52 Week low 193.65

Gross Margin % 77.61%

Net Profit Margin % 29.95%

Total Shares Outstanding 144.74M

Market Capitalization 40.06B

Biogen Inc. Common Stock Weight (BIIB) 0.04%

Dividends

Dividends Paid (Last Quarter) No Dividends

Dividends Paid (Last Fiscal Year)No Dividends

Dividends Per Share (Last Quarter) No Dividends

Dividends Yield (Last Fiscal Year) No Dividends

Dividends Per Share (Last Fiscal Year) No Dividends

Income Statement

Net Income (Last Fiscal Year) 2.96B

1 year Revenue10.17B

Last Quarter Revenue2.50B

4 months EPS revision 14.57